-transparent.png){kind=logo}
The authors studied the antiarrhythmic and antifibrillatory effects of the known antiarrhythmic agents and the new Soviet coronaroactive drug phenicaberan exhibiting an antiarrhythmic action. All the drugs were examined for side effects and the action on the central and intracardiac hemodynamics in patients with acute myocardial infarction. Recommendations have been given as to the choice of effective drugs for the prophylaxis of arrhythmias depending on the pattern of heart rhythm abnormality and the hemodynamics.
Related Publications
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1988,
Zeitschrift fur Kardiologie,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1994,
Zeitschrift fur Kardiologie,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1992,
Zeitschrift fur Kardiologie,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1992,
Therapie,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1994,
Postgraduate medical journal,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
October 1971,
Klinicheskaia meditsina,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1997,
Eksperimental'naia i klinicheskaia farmakologiia,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1972,
Farmakologiia i toksikologiia,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
March 1985,
Vrachebnoe delo,
A A Stoliarchuk, and
B G Storozhuk, and
V R Briskin
January 1990,
Pharmacological research,
